European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the Role of Metabolic Imaging in the Neoadjuvant Treatment of Gastrointestinal Cancer
Overview
Authors
Affiliations
Metabolic imaging and early response assessment by positron emission tomography (PET) are gaining importance in guiding treatment of localised and metastatic gastrointestinal tumours. During a workshop organised by the European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Tract Cancer Group the most relevant research questions, methodological aspects and unmet clinical needs in this disease were discussed. Potential future trials were drafted. This paper reviews the lectures and discussions held during this workshop and summarises the action points for the further investigation of metabolic imaging to guide treatment in gastrointestinal tumours.
Chances, risks and limitations of neoadjuvant therapy in surgical oncology.
Lordick F, Gockel I Innov Surg Sci. 2019; 1(1):3-11.
PMID: 31579713 PMC: 6753981. DOI: 10.1515/iss-2016-0004.
Schneider P, Eshmuminov D, Rordorf T, Vetter D, Veit-Haibach P, Weber A BMC Cancer. 2018; 18(1):548.
PMID: 29743108 PMC: 5944162. DOI: 10.1186/s12885-018-4477-4.
Schroer-Gunther M, Scheibler F, Wolff R, Westwood M, Baumert B, Lange S Dtsch Arztebl Int. 2015; 112(33-34):545-52.
PMID: 26356551 PMC: 4570959. DOI: 10.3238/arztebl.2015.0545.
Leccisotti L, Gambacorta M, de Waure C, Stefanelli A, Barbaro B, Vecchio F Eur J Nucl Med Mol Imaging. 2015; 42(5):657-66.
PMID: 25687534 DOI: 10.1007/s00259-014-2820-9.
Towards personalized perioperative treatment for advanced gastric cancer.
Miao R, Wu A World J Gastroenterol. 2014; 20(33):11586-94.
PMID: 25206266 PMC: 4155352. DOI: 10.3748/wjg.v20.i33.11586.